RAC 0.93% $1.62 race oncology ltd

Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett, page-133

  1. 2,708 Posts.
    lightbulb Created with Sketch. 2824
    don’t they already know that Flu+Clo just doesn’t inhibit FTO at all therefore any measurement against FTO
    and M6A levels + tumour response will validate?

    Bisantrene will inhibit FTO in humans or it won’t, this would already be known and must be disclosed if it didn’t. The effect of the tumour response is important, interested to see the data once released.

    Delay IMO is purely peer review and trade secret. The longer the better!
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.